NexBio was formed by a China-borne husband-wife team who did their early "academic work" in China, and then moved to the US to earn biology PhDs. Questionable phase 1 trials earned the company a place in SEC history. International clinical trial data were suspect, at best, but many suspected fraud from the outset.
↧